Washington University Cardiac Ablation Patent Granted
Summary
The USPTO granted US Patent 12605070B2 to Washington University covering a method for selecting ablation targets for non-invasive cardiac arrhythmia treatment using segmented mapping models. The patent names Clifford Robinson, Phillip Cuculich, and Geoffrey Hugo as inventors and contains 13 claims with filing date May 31, 2022.
What changed
The USPTO issued US Patent 12605070B2 to Washington University for a method of identifying ablation targets in cardiac arrhythmia treatment. The patent covers receiving a heart mapping, generating a segmented model dividing the mapping into segments, identifying abnormalities, determining which segments contain abnormalities, and selecting targets for non-invasive treatment based on those segments.
Medical device manufacturers developing cardiac mapping, imaging, or ablation systems should review this patent for potential licensing or design-around considerations. Competitors in the cardiac ablation space may need to conduct freedom-to-operate analysis for related technologies.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
System and method for determining segments for ablation
Grant US12605070B2 Kind: B2 Apr 21, 2026
Assignee
Washington University
Inventors
Clifford Robinson, Phillip Cuculich, Geoffrey Hugo
Abstract
A method for selecting one or more targets for non-invasively treating a cardiac arrhythmia in a patient includes receiving a mapping associated with the patient's heart and generating a segmented model of the mapping associated with the patient's heart. The segmented model divides the mapping into a plurality of segments. The method includes identifying one or more abnormality in the segmented model of the mapping associated with the patient's heart, determining which segment or segments of the plurality of segments include the identified one or more abnormality, and selecting a target for non-invasive treatment of the cardiac arrhythmia based on the determined segment or segments of the plurality of segments that include the identified one or more abnormality.
CPC Classifications
A61B 5/0036 A61B 5/0044 A61B 5/055 A61B 5/364 A61B 6/032 A61B 6/037 A61B 8/14 A61B 5/0035 A61B 5/7275 A61B 2505/05 A61B 5/361 A61B 5/363 A61B 5/367 A61B 5/7267 G16H 10/60 G06T 2207/10084 G06T 2207/20076 G06T 7/10 G06T 2207/10081 G06T 2207/10088 G06T 2207/10104 G06T 2207/10108 G06T 2207/10132 G06T 2207/20081 G06T 2207/20084 G06T 2207/20104 G06T 2207/20128 G06T 2207/20212 G06T 2207/30048 G06T 7/0012
Filing Date
2022-05-31
Application No.
17804645
Claims
13
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.